Physician profile
Clint Gregory
NPI 1730629981
$4,884.88
in general payments reported to CMS, 2019-2025
43 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $906 · 2022: $963 · 2023: $1,131 · 2024: $776 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,016.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $846.80 | 2021-2025 | |
| Novo Nordisk INC | $686.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $594.88 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $340.16 | 2021-2025 | Evenity, Prolia, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $274.81 | 2022-2025 | |
| Pfizer INC. | $265.59 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $253.61 | 2021-2025 | Invega Sustenna, Spravato |
| Glaxosmithkline, LLC. | $223.41 | 2023-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $182.52 | 2022-2025 | Airsupra, Fasenra, Breztri |
| Grifols USA, LLC | $89.84 | 2021-2024 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.43 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.79 | 2021-2024 | Trintellix |
| Sanofi-Aventis U.S. LLC | $68.24 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $62.48 | 2021 | |
| Amarin Pharma, INC. | $56.54 | 2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clint Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.